RCW
MEDP icon

Rheos Capital Works’s Medpace MEDP Stock Holding History

Rheos Capital Works’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,101
Closed -$9.13M – 77
2025
Q2 		$9.13M Hold
29,101
– – 0.53% 56
2025
Q1 		$8.87M Hold
29,101
– – 0.72% 50
2024
Q4 		$9.67M Hold
29,101
– – 0.54% 68
2024
Q3 		$9.71M Buy
29,101
+4,500
+18% +$1.71M 0.51% 77
2024
Q2 		$10.1M Hold
24,601
– – 0.53% 59
2024
Q1 		$9.94M Buy
+24,601
New +$8.65M 0.48% 71

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rheos Capital Works's MEDP Position: Q3 2025 in Review

Rheos Capital Works sold out of Medpace (MEDP) in Q3 2025, closing a stake of 29,101 shares — an estimated $9.13M sold.

Rheos Capital Works first reported a position in MEDP in Q1 2024 and held it in 6 quarters. The position peaked at $10.1M in Q2 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Rheos Capital Works reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Rheos Capital Works sold 29,101 Medpace shares in Q3 2025, an estimated $9.13M.
  • Rheos Capital Works first reported a position in Medpace in Q1 2024 and held it in 6 quarters.
  • Rheos Capital Works's Medpace position peaked at $10.1M in Q2 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Rheos Capital Works's 13F filing for Q3 2025, filed 22 Oct 2025.